RENACIDIN
CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE
Approval overview RENACIDIN is listed in Drugs@FDA under application 019481 (NDA).
Review priority: PRIORITY Marketing status: Prescription Active ingredient CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE Form and strength SOLUTION;IRRIGATION - 6.602GM/100ML;198MG/100ML;3.177GM/100ML Sponsor UNITED GUARDIAN Submission history Latest submission status date: 2015-12-16 00:00:00.
Structured Monograph
Clinical summary
Approval overview RENACIDIN is listed in Drugs@FDA under application 019481 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE Form and strength SOLUTION;IRRIGATION - 6.602GM/100ML;198MG/100ML;3.177GM/100ML Sponsor UNITED GUARDIAN Submission history Latest submission status date: 2015-12-16 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.